Hear the World - Apply for Funding until January 31

Digital application

The cost of hearing aids

Cost of hearing aids is an issue

Get the latest news of the profession: sign up for our newsletter!

Audiology Worldnews newsletter

Access AWN Special 62nd EUHA Congress (free-access flipbook)

AWN EUHA 2017 special issue

Interested in Audiology-related events?

Audiology Worldnews agenda

3D-TUNE-IN: facilitating hearing aid use through gaming

partnership

© iStock

The project 3D-TUNE-IN, short for 3D-games for TUNing and lEarnINg about hearing aids, was recently launched with 3-year funding from the EU under Horizon 2020. 3D-TUNE-IN will be coordinated by the recently established Dyson School of Design Engineering of Imperial College London, and includes 9 university and industry partners from Italy, Spain and the United Kingdom. Partners include the SME digital games industry (Reactify, Vianet, XTeam and Nerlaska), academic institutions, a large European hearing aids manufacturer (GN Hearing), and representatives of the hearing-impaired community.

Optimal use of hearing aids is essential for people with hearing impairment to truly benefit from the devices. Elderly patients are often found to prefer simple devices or to use only the basic amplification and equalization features of more advanced ones. However, more technologically advanced devices offer real improvements in certain hearing environments. Children also need to have simple ways of maximizing beneficial use of their hearing aids to ensure optimal speech and language development. In this context, 3D-TUNE-IN will aim to produce digital games for various target audiences and situations that can be applied to hearing aids to make the most of existing, overlooked, or neglected functionalities.

The basic idea is to apply techniques routinely used in games to non-leisure applications to develop optimal use of hearing aids. The developers are hoping that bringing the two worlds together will help to promote learning and skill acquisition, and ultimately to increase social interactions, making people with hearing impairments feel more confident and included in their communities.

Source: European Commission

C.S.

Early detection is still an uphill struggle in 2018
Early detection is still an uphill struggle in 2018

Hearing loss detection

Mónica Matos Rodeo, audiologist at the Los Andes Paediatric Society and the Child Cardiovascular Hospital in Cundinamarca, Colombia © MBP

Policy makers in Colombia are yet to approve the implementation of a national screening programme for hearing loss; meanwhile, children between 5 and 7 years old are being diagnosed through techniques that lack endorsement as decisive methods.

Oticon Inc. appoints new Executive, Marketing and Sales Directors
Oticon Inc. appoints new Executive, Marketing and Sales Directors

Management

Dawn Spring (l.) and Josephine Poelma (r.) © Oticon

Oticon Inc. has announced the appointment of two Executive Directors and six Directors in marketing and sales.

Priorities for future research in hyperacusis
 Priorities for future research in hyperacusis

Hyperacusis

© bowie15 - iStock.com

Researchers working at Nottingham Biomedical Research Centre and the University of Nottingham, UK recently examined the most important research questions in hyperacusis.

Oricula Therapeutics: investigational new drug approved
Oricula Therapeutics: investigational new drug approved

Biotech

© scanrail - iStock.com

Oricula Therapeutics recently announced United States FDA approval for volunteer human studies of the safety, tolerability, and pharmacokinetics of a novel medicine, ORC-13661 in hearing protection.

Spain hearing aid sales rally in 2017
Spain hearing aid sales rally in 2017

Figures

J.L.F.

The annual report from the GEA (Audiological Business Group)—issued now for the last three years—shows growth in the number of hearing aids sold in Spain for the financial year, 2017, a notable climb up of 3.7% (one percentage point more) on 2016.

Adding crizotinib to radiation therapy may reduce hearing damage
Adding crizotinib to radiation therapy may reduce hearing damage

Therapy

© sanjeri - istock.com

Researchers at the Massachusetts General Hospital in Boston recently published the results of a mouse model study showing a new therapeutic combination that may be of interest in patients with neurofibromatosis 2 (NF2) and other patient groups.

A reminder of the commonly used drugs that are potentially ototoxic
A reminder of the commonly used drugs that are potentially ototoxic

Ototoxicity

© Mukhina1 - istock.com

Pharmacy Times, a full-service pharmacy media resource, recently reported on the main drugs that can cause damage to hearing, and highlighted their mechanisms of action.

Company Directory

New products

MED-EL launches tablet-based planning tool OTOPLAN

MED-EL and CAScination have today announced the launch of a surgical planning software at the 31st Politzer Society meeting in Gran Canaria.

 [ ... ]

Phonak extends its rechargeable portfolioPhonak extends its rechargeable portfolio

Phonak Sky™ B

Phonak has extended its latest-generation Belong platform with Phonak Naída™ B and Phonak Sky™ B hearing aids.  [ ... ]

Grason-Stadler releases AMTAS FlexGrason-Stadler releases AMTAS Flex

GSI announced the release of AMTAS Flex™, a new tablet-based hearing evaluation tool designed with the busy clinician in mind.  [ ... ]